Some investment analysts are predicting a more permissive M&A market, deregulation as a catalyst for growth and fiscal policies that stimulate economic activity. And they see AI as a catalyst in the shift. 

The 24 members of the House Task Force on AI—12 reps from each party—have posted a 253-page report detailing their bipartisan vision for encouraging innovation while minimizing risks. 

When regulating AI-equipped medical devices, the FDA might take a page from the Department of Transportation’s playbook for overseeing AI-equipped vehicles. These run the gamut from assisting human drivers to fully taking the wheel. 

Intensive care units around the world use daily diaries to track patients’ emotional as well as physical ups and downs. Many find that keeping these helpful resources can add to nurses’ already-heavy workloads. How might generative AI help? 

The year 2023 saw a shift toward open-source AI models, surging investments in generative AI and increasing AI regulation.

A large venture capital firm focused on supporting early-stage healthtech companies has a tip for AI startups targeting the healthcare sector.

Given the rapid proliferation of AI-equipped medical devices across U.S. healthcare, unintended effects should surprise no one. 

The FDA’s fledgling Digital Health Advisory Committee (DHAC) only held its first meeting last week, but it has already committed its thinking to writing.